The administration of neurofibromatosis kind 2 (NF2)-associated meningiomas is difficult. The function of Gamma Knife radiosurgery (GKRS) within the therapy of those tumors stays to be totally outlined. On this examine, the authors aimed to look at the function of GKRS within the therapy of NF2-associated meningiomas and to judge the outcomes and problems after therapy. Seven worldwide medical facilities contributed knowledge for this retrospective cohort. Tumor development was outlined as a ≥ 20% improve from the baseline worth. The medical options, therapy particulars, outcomes, and problems have been studied.
The median follow-up was 8.5 years (vary 0.6-25.5 years) from the time of preliminary GKRS. Shared frailty Cox regression was used for evaluation. A complete of 204 meningiomas in 39 sufferers handled with GKRS have been analyzed. Cox regression evaluation confirmed that growing the utmost dose (p = 0.02; HR 12.2, 95% CI 1.287-116.7) and a decrease variety of meningiomas at presentation (p = 0.03; HR 0.9, 95% CI 0.821-0.990) have been predictive of higher tumor management in each univariable and multivariable settings. Age at onset, intercourse, margin dose, location, and presence of neurological deficit weren’t predictive of tumor development.
The cumulative 10-year progression-free survival was 94.8%. Radiation-induced opposed results have been famous in Four sufferers (10%); these have been transient and managed medically. No post-GKRS malignant transformation was famous in 287 person-years of follow-up. GKRS achieved efficient tumor management with a low and usually acceptable charge of problems in NF2-associated meningiomas. There didn’t seem like an considerable danger of post-GKRS-induced malignancy in sufferers with NF2-treated meningiomas.
Efficacy of Cannabinoids on Spasticity and Power Ache in a Affected person with Co-occurrence of A number of Sclerosis and Neurofibromatosis Sort 1
Neurofibromatosis kind 1 (NF1) is a uncommon autosomal dominant illness involving the pores and skin and central nervous system (CNS), and in addition characterised by skeletal and spinal schwannomas which will trigger power neurogenic ache. Moreover, ache in NF1 is underestimated, despite the fact that it has an influence on high quality of life. A number of sclerosis (MS) is the most typical acquired demyelinating illness which will in later phases current with refractory spasticity, significantly within the decrease limbs. Oromucosal cannabinoid sprays are at the moment obtainable for spasticity therapy in MS, with encouraging outcomes on MS ache, however few knowledge have been reported relating to using cannabinoids in NF1. We report the profitable therapy of power neurogenic ache and spasticity in a affected person with co-occurrence of NF1 and MS after a poor response to plain approaches.
Neurofibromatosis kind 1 (NF1) is a genetic multisystem dysfunction. Clinicians should pay attention to the various medical options of this dysfunction in an effort to present optimum look after it. We’ve got arrange an NF1 in-hospital medical care community of specialists no matter affected person age, launching a multidisciplinary method to the illness for the primary time in Japan. From January 2014 to December 2020, 246 sufferers have been enrolled within the NF1 affected person record and medical information. Imply age was 26.Zero years starting from Three months to 80 years. The variety of sufferers was greater as age at first go to was decrease. There have been 107 males (41%) and 139 females.
After 2011, the variety of sufferers has elevated because the yr when the medical care community was began. Concerning orthopedic indicators, scoliosis was current in 60 instances (26%), and bone abnormalities within the higher arm, forearm, and tibia in Eight instances (3.5%). Neurofibromas aside from cutaneous neurofibromas have been current in 90 instances (39%), and MPNST in 17 instances (7.4%). We launched a multidisciplinary NF1 clinic system for the primary time in Japan. For sufferers with NF1, which is a hereditary and systemic illness related to a excessive incidence of malignant tumors, it will likely be of nice profit when the variety of such clinics in Japan and the remainder of Asia is elevated.
DINs: Deep Interactive Networks for Neurofibroma Segmentation in Neurofibromatosis Sort 1 on Entire-Physique MRI
Neurofibromatosis kind 1 (NF1) is an autosomal dominant tumor predisposition syndrome that includes the central and peripheral nervous techniques. Correct detection and segmentation of neurofibromas are important for assessing tumor burden and longitudinal tumor dimension adjustments. Computerized convolutional neural networks (CNNs) are delicate and susceptible as tumors’ variable anatomical location and heterogeneous look on MRI. On this examine, we suggest deep interactive networks (DINs) to deal with the above limitations. Consumer interactions information the mannequin to acknowledge difficult tumors and shortly adapt to heterogeneous tumors.
We introduce a easy however efficient Exponential Distance Remodel (ExpDT) that converts consumer interactions into information maps considered the spatial and look prior. Evaluating with standard Euclidean and geodesic distances, ExpDT is extra sturdy to varied picture sizes, which reserves the distribution of interactive inputs. Moreover, to reinforce the tumor-related options, we design a deep interactive module to propagate the guides into deeper layers. We practice and consider DINs on three MRI knowledge units from NF1 sufferers. The experiment outcomes yield vital enhancements of 44% and 14% in DSC evaluating with automated and different interactive strategies, respectively. We additionally experimentally exhibit the effectivity of DINs in lowering consumer burden when evaluating with typical interactive strategies.
 Sulfo-Cyanine7 bis-NHS ester, 100 mg |
|
653D0 |
Lumiprobe |
100 mg |
EUR 1711.2 |
 Sulfo-Cyanine7 NHS ester, 25 mg |
|
45320 |
Lumiprobe |
25 mg |
EUR 615.6 |
 Sulfo-Cyanine3 NHS ester, 50 mg |
|
51320 |
Lumiprobe |
50 mg |
EUR 1105.2 |
 Sulfo-Cyanine5 NHS ester, 5 mg |
|
23320 |
Lumiprobe |
5 mg |
EUR 280.8 |
 Sulfo-Cyanine7 NHS ester, 1 mg |
|
15320 |
Lumiprobe |
1 mg |
EUR 129.6 |
 Sulfo-Cyanine7.5 NHS ester, 1 mg |
|
16320 |
Lumiprobe |
1 mg |
EUR 129.6 |
 Sulfo-NHS-Biotin |
|
2322-250 |
Biovision |
each |
EUR 836.4 |
Sulfo-NHS-Biotin |
|
2322-50 |
Biovision |
each |
EUR 274.8 |
Sulfo-NHS-Biotin |
|
2322-set |
Biovision |
each |
EUR 222 |
Sulfo-NHS-Biotin |
|
A8001-100 |
ApexBio |
100 mg |
EUR 60 |
|
|
|
Description: Biotinylation Reagents|Amine Biotinylation Reagents |
Sulfo-NHS-Biotin |
|
A8001-1000 |
ApexBio |
1 g |
EUR 588 |
|
Description: Sulfo-NHS-Biotin (N-Hydroxysulfosuccinimidobiotin) is an amine-reactive biotinylation reagent. The most common amine-reactive biotinylation reagents can be divied into two basic types, N-hydroxysuccinimide (NHS) esters and carboxylates. |
Sulfo-NHS-Biotin |
|
MBS3840686-100mg |
MyBiosource |
100mg |
EUR 220 |
Sulfo-NHS-Biotin |
|
MBS3840686-5x1g |
MyBiosource |
5x1g |
EUR 3870 |
Sulfo-NHS-Biotin |
|
MBS5756281-100mg |
MyBiosource |
100mg |
EUR 290 |
Sulfo-NHS-Biotin |
|
MBS5756281-10mg |
MyBiosource |
10mg |
EUR 155 |
Sulfo-NHS-Biotin |
|
MBS5756281-25mg |
MyBiosource |
25mg |
EUR 195 |
Sulfo-NHS-Biotin |
|
MBS5756281-50mg |
MyBiosource |
50mg |
EUR 240 |
Sulfo-NHS-Biotin |
|
MBS5756281-5mg |
MyBiosource |
5mg |
EUR 145 |
Sulfo-NHS-Biotin |
|
T19952-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
|
|
Description: Sulfo-NHS-Biotin |
Sulfo-NHS-Biotin |
|
T19952-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
|
|
Description: Sulfo-NHS-Biotin |
Sulfo-NHS-Biotin |
|
T19952-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
|
|
Description: Sulfo-NHS-Biotin |
Sulfo-NHS-Biotin |
|
T19952-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
|
|
Description: Sulfo-NHS-Biotin |
-Biotin) sulfo-LC-(+)-Biotin |
|
20-abx185570 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
|
 sulfo-Cyanine3 DBCO, 100 mg |
|
613F0 |
Lumiprobe |
100 mg |
EUR 1711.2 |
 sulfo-Cyanine5 DBCO, 100 mg |
|
633F0 |
Lumiprobe |
100 mg |
EUR 1711.2 |
 Sulfo-Cyanine5.5 amine, 100 mg |
|
673C0 |
Lumiprobe |
100 mg |
EUR 1711.2 |
 Sulfo-Cyanine3 amine, 100 mg |
|
613C0 |
Lumiprobe |
100 mg |
EUR 1711.2 |
 Sulfo-Cyanine5 amine, 100 mg |
|
633C0 |
Lumiprobe |
100 mg |
EUR 1711.2 |
 Sulfo-Cyanine7 amine, 100 mg |
|
653C0 |
Lumiprobe |
100 mg |
EUR 1711.2 |
 Sulfo-Cyanine7 azide, 100 mg |
|
F5330 |
Lumiprobe |
100 mg |
EUR 1711.2 |
 Sulfo-Cyanine7.5 azide, 100 mg |
|
F6330 |
Lumiprobe |
100 mg |
EUR 1711.2 |
 Sulfo-Cyanine5.5 azide, 100 mg |
|
F7330 |
Lumiprobe |
100 mg |
EUR 1711.2 |
 Sulfo-Cyanine3 azide, 100 mg |
|
F1330 |
Lumiprobe |
100 mg |
EUR 1711.2 |
 Sulfo-Cyanine5 azide, 100 mg |
|
F3330 |
Lumiprobe |
100 mg |
EUR 1711.2 |
 Sulfo-Cyanine7 alkyne, 100 mg |
|
F53B0 |
Lumiprobe |
100 mg |
EUR 1711.2 |
 Sulfo-Cyanine7.5 alkyne, 100 mg |
|
F63B0 |
Lumiprobe |
100 mg |
EUR 1711.2 |
 Sulfo-Cyanine5.5 alkyne, 100 mg |
|
F73B0 |
Lumiprobe |
100 mg |
EUR 1711.2 |
 Sulfo-Cyanine3 alkyne, 100 mg |
|
F13B0 |
Lumiprobe |
100 mg |
EUR 1711.2 |
 Sulfo-Cyanine5 alkyne, 100 mg |
|
F33B0 |
Lumiprobe |
100 mg |
EUR 1711.2 |
 Sulfo-NHS-Biotin Kit |
|
K1005-10 |
ApexBio |
10 reactions |
EUR 181.6 |
|
|
|
Description: Biotinylation Reagents|Amine Biotinylation Reagents#Biotinylation reagents and kits|Amine Biotinylation Reagents and Kits#Labels and tags|Biotinylation Reagents#Biotinylation reagents and kits |
 Sulfo-Cyanine5.5 maleimide, 100 mg |
|
67380 |
Lumiprobe |
100 mg |
EUR 1711.2 |
 Sulfo-Cyanine3 tetrazine, 100 mg |
|
613 |
Lumiprobe |
100 mg |
EUR 1711.2 |
 Sulfo-Cyanine3 maleimide, 100 mg |
|
61380 |
Lumiprobe |
100 mg |
EUR 1711.2 |
 Sulfo-Cyanine7 tetrazine, 100 mg |
|
653 |
Lumiprobe |
100 mg |
EUR 1711.2 |
 Sulfo-Cyanine7 maleimide, 100 mg |
|
65380 |
Lumiprobe |
100 mg |
EUR 1711.2 |
 sulfo-Cyanine7.5 maleimide, 100 mg |
|
66380 |
Lumiprobe |
100 mg |
EUR 1711.2 |
) Sulfo-NHS-Biotin (sodium) |
|
HY-136964 |
MedChemExpress |
10 mg |
EUR 124.46 |
|
Description: Sulfo-NHS-Biotin (sodium) stongly label single SDS-2ME soluble cuticular protein[1]. |
 Sulfo-NHS-SS-Biotin |
|
2323-100 |
Biovision |
each |
EUR 379.2 |
Sulfo-NHS-SS-Biotin |
|
2323-50 |
Biovision |
each |
EUR 255.6 |
Sulfo-NHS-SS-Biotin |
|
2323-set |
Biovision |
each |
EUR 274.8 |
 Sulfo-NHS-LC-Biotin |
|
2326-100 |
Biovision |
each |
EUR 373.2 |
Sulfo-NHS-LC-Biotin |
|
2326-50 |
Biovision |
each |
EUR 242.4 |
Sulfo-NHS-LC-Biotin |
|
2326-set |
Biovision |
each |
EUR 255.6 |
Sulfo-NHS-LC-Biotin |
|
A8003-100 |
ApexBio |
100 mg |
EUR 120 |
|
|
|
Description: Biotinylation Reagents|Amine Biotinylation Reagents |
Sulfo-NHS-LC-Biotin |
|
A8003-1000 |
ApexBio |
1 g |
EUR 686.4 |
|
Description: Sulfo-NHS-LC-biotin (Sulfosuccinimidyl 6-(biotinamido) Hexanoate) is an amine-reactive biotinylation agent. |
Sulfo-NHS-SS-Biotin |
|
A8005-100 |
ApexBio |
100 mg |
EUR 144 |
|
|
|
Description: Biotinylation Reagents|Amine Biotinylation Reagents |
Sulfo-NHS-SS-Biotin |
|
A8005-1000 |
ApexBio |
1 g |
EUR 1034.4 |
|
Description: Sulfo-NHS-SS-biotin(sulfosuccinimidyl-20(biotinamido)ethyl-1,3-dithiopropionate) is a long-chain cleavable amine-reactive biotinylation reagent. |
Sulfo-NHS-LC-Biotin |
|
MBS3840687-100mg |
MyBiosource |
100mg |
EUR 985 |
Sulfo-NHS-LC-Biotin |
|
MBS3840687-5x100mg |
MyBiosource |
5x100mg |
EUR 4420 |
Sulfo-NHS-LC-Biotin |
|
MBS5784242-100mg |
MyBiosource |
100(mg |
EUR 345 |
Sulfo-NHS-LC-Biotin |
|
MBS5784242-1g |
MyBiosource |
1g |
EUR 1045 |
Sulfo-NHS-LC-Biotin |
|
MBS5784242-5x1g |
MyBiosource |
5x1g |
EUR 4560 |
Sulfo-NHS-LC-Biotin |
|
T34744-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
|
|
Description: Sulfo-NHS-LC-Biotin |
Sulfo-NHS-LC-Biotin |
|
T34744-1g |
TargetMol Chemicals |
1g |
Ask for price |
|
|
|
Description: Sulfo-NHS-LC-Biotin |
Sulfo-NHS-LC-Biotin |
|
T34744-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
|
|
Description: Sulfo-NHS-LC-Biotin |
Sulfo-NHS-LC-Biotin |
|
T34744-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
|
|
Description: Sulfo-NHS-LC-Biotin |
Sulfo-NHS-LC-Biotin |
|
T34744-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
|
|
Description: Sulfo-NHS-LC-Biotin |
 Sulfo-NHS |
|
21960000-1 |
Bio-WORLD |
500 mg |
EUR 123.73 |
|
|
 sulfo-NHS |
|
20-abx184386 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
|
 Sulfo-Cyanine7 bis-NHS ester, 50 mg |
|
553D0 |
Lumiprobe |
50 mg |
EUR 1105.2 |
 Sulfo-Cyanine7 bis-NHS ester, 25 mg |
|
453D0 |
Lumiprobe |
25 mg |
EUR 615.6 |
 Sulfo-Cyanine5 bis-NHS ester, 50 mg |
|
533D0 |
Lumiprobe |
50 mg |
EUR 1105.2 |
 Sulfo-Cyanine5 bis-NHS ester, 5 mg |
|
233D0 |
Lumiprobe |
5 mg |
EUR 280.8 |
 Sulfo-Cyanine5 bis-NHS ester, 25 mg |
|
433D0 |
Lumiprobe |
25 mg |
EUR 615.6 |
 Sulfo-Cyanine7 bis-NHS ester, 5 mg |
|
253D0 |
Lumiprobe |
5 mg |
EUR 280.8 |
 Sulfo-Cyanine7 bis-NHS ester, 1 mg |
|
153D0 |
Lumiprobe |
1 mg |
EUR 129.6 |
 Sulfo-Cyanine5 bis-NHS ester, 1 mg |
|
133D0 |
Lumiprobe |
1 mg |
EUR 129.6 |
 Sulfo-Cyanine5.5 carboxylic acid, 100 mg |
|
67390 |
Lumiprobe |
100 mg |
EUR 1711.2 |
 Sulfo-Cyanine3 carboxylic acid, 100 mg |
|
61390 |
Lumiprobe |
100 mg |
EUR 1711.2 |
 Sulfo-Cyanine7 carboxylic acid, 100 mg |
|
65390 |
Lumiprobe |
100 mg |
EUR 1711.2 |
 Sulfo-Cyanine7.5 carboxylic acid, 100 mg |
|
66390 |
Lumiprobe |
100 mg |
EUR 1711.2 |
 sulfo-Cyanine7 dicarboxylic acid, 100 mg |
|
1497-100mg |
Lumiprobe |
100 mg |
EUR 1711.2 |
 Sulfo-Cyanine7.5 dicarboxylic acid, 100 mg |
|
1382-100mg |
Lumiprobe |
100 mg |
EUR 1711.2 |
 Sulfo-NHS-LC-Biotin Kit |
|
K1001-10 |
ApexBio |
10 reactions |
EUR 181.6 |
|
|
|
Description: Biotinylation Reagents|Amine Biotinylation Reagents#Biotinylation reagents and kits|Amine Biotinylation Reagents and Kits#Labels and tags|Biotinylation Reagents#Biotinylation reagents and kits |
 Sulfo-NHS-SS-Biotin Kit |
|
K1006-10 |
ApexBio |
10 reactions |
EUR 181.6 |
|
|
|
Description: Biotinylation Reagents|Amine Biotinylation Reagents#Biotinylation reagents and kits|Amine Biotinylation Reagents and Kits#Labels and tags|Biotinylation Reagents#Biotinylation reagents and kits |
 Sulfo-NHS-SS-11-Biotin |
|
A8015-100 |
ApexBio |
100 mg |
EUR 76 |
|
|
|
Description: Protein Labeling|Biotinylation Reagents |
Sulfo-NHS-SS-11-Biotin |
|
A8015-1000 |
ApexBio |
1 g |
EUR 560 |
|
|
|
Description: Protein Labeling|Biotinylation Reagents |
) Sulfo-NHS-SS-Biotin (sodium) |
|
HY-111496 |
MedChemExpress |
10 mg |
EUR 487.02 |
|
Description: Sulfo-NHS-SS-biotin is a long-chain cleavable and cell-impermeant amine-reactive biotinylation reagent. Sulfo-NHS-SS-biotin can be used for the labeling and purifying of cell-surface protein[1]. |
 Sulfo-NHS-SS-Biotin sodium |
|
MBS5771776-100mg |
MyBiosource |
100mg |
EUR 285 |
Sulfo-NHS-SS-Biotin sodium |
|
MBS5771776-10mg |
MyBiosource |
10mg |
EUR 150 |
Sulfo-NHS-SS-Biotin sodium |
|
MBS5771776-50mg |
MyBiosource |
50mg |
EUR 215 |
Sulfo-NHS-SS-Biotin sodium |
|
MBS5771776-5x100mg |
MyBiosource |
5x100mg |
EUR 1130 |
 Sulfo-NHS-LC-Biotin sodium |
|
MBS5799838-100mg |
MyBiosource |
100(mg |
EUR 315 |
Sulfo-NHS-LC-Biotin sodium |
|
MBS5799838-10mg |
MyBiosource |
10(mg |
EUR 195 |
Sulfo-NHS-LC-Biotin sodium |
|
MBS5799838-50mg |
MyBiosource |
50(mg |
EUR 220 |
Sulfo-NHS-SS-Biotin sodium |
|
T19061-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
|
|
Description: Sulfo-NHS-SS-Biotin sodium |
Sulfo-NHS-SS-Biotin sodium |
|
T19061-1g |
TargetMol Chemicals |
1g |
Ask for price |
|
|
|
Description: Sulfo-NHS-SS-Biotin sodium |
Sulfo-NHS-SS-Biotin sodium |
|
T19061-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
|
|
Description: Sulfo-NHS-SS-Biotin sodium |
Sulfo-NHS-SS-Biotin sodium |
|
T19061-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
|
|
Description: Sulfo-NHS-SS-Biotin sodium |
Sulfo-NHS-SS-Biotin sodium |
|
T19061-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
|
|
Description: Sulfo-NHS-SS-Biotin sodium |
Sulfo-NHS-LC-Biotin sodium |
|
T39340-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
|
|
Description: Sulfo-NHS-LC-Biotin sodium |
Sulfo-NHS-LC-Biotin sodium |
|
T39340-1g |
TargetMol Chemicals |
1g |
Ask for price |
|
|
|
Description: Sulfo-NHS-LC-Biotin sodium |
Sulfo-NHS-LC-Biotin sodium |
|
T39340-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
|
|
Description: Sulfo-NHS-LC-Biotin sodium |
Sulfo-NHS-LC-Biotin sodium |
|
T39340-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
|
|
Description: Sulfo-NHS-LC-Biotin sodium |
Sulfo-NHS-LC-Biotin sodium |
|
T39340-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
|
|
Description: Sulfo-NHS-LC-Biotin sodium |
 Sulfo-Cyanine 3 NHS ester |
|
263 |
AAT Bioquest |
10 mg |
EUR 570 |
|
Description: A variety of cyanine dyes has been used to label biological molecules for fluorescence imaging and other fluorescence-based biochemical analysis. |
Sulfo-Cyanine 3 NHS ester |
|
263-10mg |
AAT Bioquest |
10 mg |
EUR 558 |
|
|
|
Description: A variety of cyanine dyes has been used to label biological molecules for fluorescence imaging and other fluorescence-based biochemical analysis. |
Sulfo-Cyanine 3 NHS ester |
|
264 |
AAT Bioquest |
50 mg |
EUR 1667 |
|
Description: A variety of cyanine dyes has been used to label biological molecules for fluorescence imaging and other fluorescence-based biochemical analysis. |
Sulfo-Cyanine 3 NHS ester |
|
264-50mg |
AAT Bioquest |
50 mg |
EUR 1634 |
|
|
|
Description: A variety of cyanine dyes has been used to label biological molecules for fluorescence imaging and other fluorescence-based biochemical analysis. |
 Sulfo-Cyanine 5 NHS ester |
|
268 |
AAT Bioquest |
10 mg |
EUR 570 |
|
Description: A variety of cyanine dyes has been used to label biological molecules for fluorescence imaging and other fluorescence-based biochemical analysis. |
Sulfo-Cyanine 5 NHS ester |
|
268-10mg |
AAT Bioquest |
10 mg |
EUR 558 |
|
|
|
Description: A variety of cyanine dyes has been used to label biological molecules for fluorescence imaging and other fluorescence-based biochemical analysis. |
Sulfo-Cyanine 5 NHS ester |
|
269 |
AAT Bioquest |
50 mg |
EUR 1667 |
|
Description: A variety of cyanine dyes has been used to label biological molecules for fluorescence imaging and other fluorescence-based biochemical analysis. |
Sulfo-Cyanine 5 NHS ester |
|
269-50mg |
AAT Bioquest |
50 mg |
EUR 1634 |
|
|
|
Description: A variety of cyanine dyes has been used to label biological molecules for fluorescence imaging and other fluorescence-based biochemical analysis. |
 Sulfo-NHS Acetate |
|
21960001-1 |
Bio-WORLD |
100 mg |
EUR 162.04 |
|
|
 Sulfo-NHS-Acetate |
|
HY-140341 |
MedChemExpress |
100 mg |
EUR 114.72 |
|
Description: Sulfo-NHS-Acetate is an alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs[1]. |
Sulfo-NHS-Acetate |
|
T16959-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
|
|
Description: Sulfo-NHS-Acetate |
Sulfo-NHS-Acetate |
|
T16959-1g |
TargetMol Chemicals |
1g |
Ask for price |
|
|
|
Description: Sulfo-NHS-Acetate |
Sulfo-NHS-Acetate |
|
T16959-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
|
|
Description: Sulfo-NHS-Acetate |
Sulfo-NHS-Acetate |
|
T16959-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
|
|
Description: Sulfo-NHS-Acetate |
Sulfo-NHS-Acetate |
|
T16959-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
|
|
Description: Sulfo-NHS-Acetate |
 Biotin alkyne, 100 mg |
|
F37B0 |
Lumiprobe |
100 mg |
EUR 384 |
Diffuse tracheobronchial neurofibromatosis is a uncommon situation and its medical manifestations embrace obstruction, cough, wheezing and dyspnea. Moreover, the restricted quantity of information makes therapy selections difficult. As well as, airway papillomatosis tends to have an effect on the higher airway and the larynx, within the type of well-delimited lesions resulting in obstruction, predominantly in youngsters. Diffuse involvement of the trachea and the bronchial tree, in addition to its affiliation with neurofibromatosis, have been not often reported in adults.
